ANAB Anaptysbio, Inc

$57.49 +1.34%

Healthcare · Pharmaceutical Preparations

Anaptysbio, Inc (ANAB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.7 billion. Shares last traded at $57.49, 21.3% below their 52-week high. Over the past year the stock is up 140.9%. Net profit margin is -5.6%, below the peer median of -0.1%. Revenue grew 157.0% year over year.

Market Cap

$1.7B

Shares Out

29.1M

EPS (TTM)

$-7.90

P/E Ratio

—

P/S Ratio

7.13

P/B Ratio

131.25

Dividend / Share

—

Dividend Yield

—

52-Week High

$73.01

52-Week Low

$17.18

Volume

14,485

Avg Vol (3m)

27,682.444

Performance

+6.00%

-3.93%

-11.12%

+27.51%

YTD

+27.90%

+140.95%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.43

SMA (50)

$60.37

SMA (200)

$47.73

Price vs SMA50

-4.78%

Price vs SMA200

+20.45%

ATR (14)

$3.60

Financials

Revenue

$235M

Net Income

$-13M

Gross Margin

—

Operating Margin

20.4%

Net Margin

-5.6%

Return on Equity

-103.8%

Return on Assets

-4.0%

Current Ratio

7.58

Debt / Equity

—

Revenue Growth (YoY)

+157.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.84	2026-05-12
FY 2025	$-0.46	2026-03-03
Q3 2025	$-2.16	2025-11-04
Q2 2025	$-2.62	2025-08-06
Q1 2026	$-1.28	2026-05-12
FY 2025	$-5.12	2026-03-03

Full earnings history →

Pharmaceutical Preparations peers

ANAB vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

7.13 / 3.54 med

+102% premium

Net margin vs peers

-5.6% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.